March 10, 2026

Disclaimer: The information provided here is for educational purposes only and is not intended as medical advice. It should not be used to diagnose, treat, cure, or prevent any medical condition. Instead, use it as a starting point for discussion with your healthcare provider. Always consult with a qualified healthcare provider before starting any new medication, supplement, device, or making changes to your health regimen.
For many individuals living with Postural Orthostatic Tachycardia Syndrome (POTS) and other forms of dysautonomia, eating a meal can feel like navigating a minefield. You might sit down to enjoy a seemingly harmless plate of pasta or a sandwich, only to find yourself overwhelmed by a racing heart, profound dizziness, brain fog, and an exhaustion so deep it forces you to lie down. This phenomenon, often dismissed by those unfamiliar with chronic illness as a simple "food coma," is actually a complex, physiological crisis driven by the intricate relationship between blood sugar regulation, gastrointestinal hormones, and the autonomic nervous system.
In the world of complex chronic conditions, the intersection of blood sugar and dysautonomia is a rapidly evolving area of medical research. When the autonomic nervous system misfires, the body's ability to manage blood flow and regulate glucose becomes severely compromised. For patients with POTS, consuming carbohydrates can trigger a cascade of events—from massive blood pooling in the gut to reactive hypoglycemia and subsequent adrenaline surges—that perfectly mimic, and actively cause, debilitating symptom flares. Understanding these mechanisms is the first step toward reclaiming control over your body and your nutrition.
Living with Postural Orthostatic Tachycardia Syndrome (POTS) often means dealing with a highly reactive and unpredictable body. Many patients report that their most severe symptom flares occur shortly after eating, a phenomenon known clinically as postprandial exacerbation. This isn't just a mild feeling of sluggishness; it is a profound physiological event characterized by orthostatic intolerance, extreme tachycardia, presyncope (feeling faint), and debilitating fatigue. For years, patients have described these post-meal crashes to their providers, only to be met with confusion or the suggestion that they are simply experiencing normal digestion.
However, validating research now confirms that these postprandial symptoms are a hallmark of dysautonomia. When a healthy person eats, their body seamlessly orchestrates a complex series of hormonal and cardiovascular adjustments to digest the food. In a body with a malfunctioning autonomic nervous system, this orchestration fails spectacularly. The simple act of consuming a meal, particularly one high in carbohydrates, places an enormous stress load on a circulatory system that is already struggling to maintain adequate blood flow to the brain and heart.
This post-meal crash is incredibly disruptive to daily life. It can make eating at work or in social situations a source of intense anxiety, as patients fear the inevitable onset of symptoms. Understanding that this reaction is rooted in measurable, biological dysfunction—specifically related to how the body processes glucose and manages blood volume—is deeply validating for those who have spent years searching for answers. It shifts the narrative from a mysterious intolerance to a clear, manageable physiological mechanism.
To understand why eating triggers POTS symptoms, we must first look at the mechanics of normal digestion. When food enters the stomach and small intestine, the body must divert a significant amount of blood flow to the gastrointestinal (GI) tract to absorb nutrients, a process known as splanchnic perfusion. In a healthy individual, the autonomic nervous system compensates for this shift by slightly constricting blood vessels in other parts of the body and marginally increasing cardiac output, ensuring that blood pressure remains stable and the brain remains perfectly oxygenated.
In individuals with dysautonomia, this compensatory mechanism is fundamentally broken. The autonomic nervous system fails to adequately constrict the peripheral blood vessels. Consequently, when blood is diverted to the gut for digestion, it pools there in massive quantities—a phenomenon known as splanchnic blood pooling. Because the blood vessels cannot tighten to push the blood back up against gravity, a significant portion of the body's blood volume becomes trapped in the abdominal region, leaving the rest of the body desperately short of oxygenated blood.
This massive diversion of blood is why digestion demands so much energy and why it is so taxing for POTS patients. The body is essentially forced into a state of acute hypovolemia (low blood volume) every time a large meal is consumed. This lack of blood flow to the brain is a primary driver of the severe brain fog and cognitive dysfunction that patients frequently experience after eating, making it nearly impossible to concentrate or think clearly.
The splanchnic blood pooling triggered by digestion directly leads to a dangerous drop in stroke volume—the amount of blood the heart pumps with each beat. When the heart is deprived of adequate venous return (blood coming back from the body), it cannot pump enough blood out to the brain and vital organs. The body's baroreceptors (pressure sensors) instantly detect this drop in blood pressure and send panic signals to the brain, initiating a massive sympathetic nervous system response to keep the patient from passing out.
To compensate for the low stroke volume, the brain commands the heart to beat significantly faster, resulting in the severe tachycardia that defines POTS. The heart races frantically, attempting to circulate the diminished available blood volume. This compensatory tachycardia is exhausting; it feels like running a marathon while sitting still. The patient experiences palpitations, chest tightness, and a profound sense of physical anxiety, all driven by the heart's desperate attempt to maintain perfusion.
Crucially, this vicious cycle is heavily influenced by the macronutrient composition of the meal. Clinical surveys indicate that up to 53% of POTS patients report worsened symptoms after high-carbohydrate meals, compared to only 15% after high-protein meals. As we will explore in the following sections, carbohydrates trigger a unique hormonal cascade that aggressively dilates the blood vessels in the gut, making the splanchnic pooling—and the resulting compensatory tachycardia—exponentially worse than when consuming proteins or fats.
The connection between carbohydrate consumption and severe POTS flares lies in a group of gastrointestinal hormones known as incretins. When you consume glucose or complex carbohydrates, the gut immediately releases incretin hormones, primarily Glucagon-like peptide-1 (GLP-1) and Glucose-dependent insulinotropic polypeptide (GIP). These hormones are designed to signal the pancreas to prepare for an influx of sugar by producing insulin. However, in the context of dysautonomia, GIP plays a much more sinister role.
Research has revealed that GIP acts as a potent splanchnic vasodilator. This means that when GIP is released into the bloodstream, it actively forces the blood vessels in the gastrointestinal tract to dilate, or widen, significantly. In a healthy person, this vasodilation is minor and easily managed. But in a POTS patient, whose blood vessels already struggle to constrict, the release of GIP causes a catastrophic opening of the abdominal vascular bed, leading to immediate and severe blood pooling.
The more simple carbohydrates or sugars a patient consumes, the larger the spike in GIP, and consequently, the more severe the splanchnic vasodilation. This hormonal mechanism explains why a sugary drink or a large plate of pasta can trigger a POTS episode so rapidly. The GIP surge actively works against the body's already compromised ability to maintain vascular tone, turning a normal digestive process into a cardiovascular crisis.
The metabolic chaos doesn't end with GIP and blood pooling; it extends into the realm of blood sugar regulation and insulin dynamics. When the exaggerated release of incretins signals the pancreas, it often results in an overproduction of insulin (hyperinsulinemia). This massive insulin spike aggressively drives glucose out of the bloodstream and into the cells, causing blood sugar levels to plummet rapidly a few hours after the meal. This phenomenon is known as reactive hypoglycemia.
When blood sugar drops too quickly, the brain perceives it as a life-threatening emergency. To prevent a hypoglycemic coma, the autonomic nervous system triggers a massive release of counter-regulatory stress hormones, primarily cortisol, epinephrine (adrenaline), and norepinephrine. In a dysautonomic nervous system that is already hyper-reactive, this "adrenaline dump" is explosive. It causes severe tremors, sweating, profound anxiety, and extreme tachycardia.
For many POTS patients, this adrenaline dump is indistinguishable from a primary autonomic flare or a panic attack. The sudden surge of norepinephrine exacerbates the existing sympathetic overdrive characteristic of POTS. Patients are left trapped in a terrifying cycle: the meal causes blood pooling and tachycardia, followed hours later by a reactive hypoglycemic crash that triggers a massive adrenaline surge, causing yet another wave of severe cardiovascular and neurological symptoms.
To fully grasp the severity of these mechanisms, we must consider the baseline state of a POTS patient's circulatory system. A vast majority of individuals with POTS suffer from central hypovolemia, meaning they have an abnormally low total blood volume. Their bodies simply do not hold onto enough fluid and sodium to keep the blood vessels adequately filled. This chronic low blood volume is a primary driver of their daily orthostatic intolerance and fatigue.
When you introduce the digestive demands of a high-carbohydrate meal into a body that is already hypovolemic, the results are disastrous. The body simply does not have enough "spare" blood to send to the gut without severely compromising blood flow to the rest of the body. The splanchnic pooling induced by GIP drains the already depleted central reservoir, causing a precipitous drop in cerebral perfusion (blood flow to the brain).
This severe lack of cerebral blood flow is what transforms a simple meal into a debilitating event. The brain, starved of oxygen and glucose due to the sudden shift in blood volume, cannot function properly. This manifests as intense brain fog, difficulty speaking, blurred vision, and an overwhelming need to lie flat to allow gravity to return blood to the head. Managing blood sugar and digestion in POTS is therefore inextricably linked to managing overall blood volume.
The biological mechanisms linking carbohydrate consumption to POTS flares are not merely theoretical; they have been rigorously documented in clinical research. A landmark 2022 prospective, case-control study published in the journal Hypertension by Breier et al. at Vanderbilt University provided definitive proof of this connection. The researchers sought to understand exactly why POTS patients experience severe postprandial symptom worsening by measuring their hemodynamic and hormonal responses to a standardized glucose challenge.
In this study, 12 women with POTS and 13 age-matched healthy controls were given a 75-gram oral glucose drink. The results were striking. Following glucose consumption, the upright heart rate in POTS patients surged significantly by 21.2%, compared to a mere 6.0% increase in the healthy controls. Simultaneously, the POTS patients experienced a severe decline in upright stroke volume of -10.3%, whereas the healthy controls actually saw a slight increase in stroke volume.
Crucially, the researchers tracked the hormonal changes driving this cardiovascular collapse. They found that the POTS patients exhibited drastically elevated plasma levels of GIP and C-peptide (a marker of insulin production) compared to the controls. The study concluded that the time-dependent spike in GIP directly correlated with the sudden drop in stroke volume and the worsening upright tachycardia, providing concrete evidence that glucose-induced incretin release actively drives splanchnic vasodilation and POTS flares.
Further research has illuminated the high prevalence of reactive hypoglycemia in the dysautonomia population. A 2024 clinical series evaluating patients with Hypermobile Ehlers-Danlos Syndrome (hEDS)—a connective tissue disorder highly comorbid with POTS—found a profound incidence of metabolic dysfunction. In this cohort, all evaluated EDS/POTS patients experienced reactive hypoglycemia, with capillary glucose levels dropping as dangerously low as 39 mg/dL after meals, triggering severe autonomic crises.
Recent presentations at the Endocrine Society have also highlighted the utility of Continuous Glucose Monitors (CGMs) in diagnosing these invisible crashes. In case studies of dysautonomia patients experiencing unexplained syncope (fainting) and severe tachycardia, CGM data confirmed frequent postprandial blood glucose drops below 80 mg/dL. These drops corresponded precisely with the onset of their most severe dysautonomia symptoms, proving that the "adrenaline dump" triggered by rapidly falling blood sugar is a primary instigator of autonomic flares.
This research is critical because it highlights a frequent area of misdiagnosis. Many POTS patients who experience these severe, shaking, tachycardic episodes after eating are misdiagnosed with panic disorder or anxiety. Standard fasting glucose tests or A1C measurements often return normal results, missing the dynamic, post-meal dysfunction. The research clearly shows that these episodes are not psychological; they are severe physiological reactions driven by the autonomic nervous system's desperate attempt to correct a rapidly crashing blood sugar level.
The relationship between POTS and blood sugar is bidirectional; not only does blood sugar affect the autonomic nervous system, but autonomic dysfunction also impairs glucose metabolism. POTS is characterized by chronic sympathetic nervous system overdrive, meaning the body is constantly flooded with high levels of norepinephrine (the "fight or flight" neurotransmitter). Research suggests that this chronic sympathetic activation can actually induce cellular insulin resistance over time.
When cells become resistant to insulin due to constant stress hormone exposure, the pancreas must pump out disproportionately massive amounts of insulin to clear glucose from the bloodstream. This hyperinsulinemia sets the stage for the violent reactive hypoglycemic crashes described earlier. Even lean POTS patients frequently exhibit impaired glucose tolerance and require higher amounts of insulin to process standard amounts of sugar, bordering on early metabolic dysfunction.
This creates a devastating feedback loop. The sympathetic overdrive causes insulin resistance, which leads to exaggerated insulin spikes and subsequent blood sugar crashes. These crashes then trigger massive adrenaline dumps, which further exacerbate the sympathetic overdrive and worsen the POTS symptoms. Breaking this cycle requires a targeted approach to stabilizing blood glucose and calming the autonomic nervous system simultaneously.
When managing the metabolic and cardiovascular chaos of POTS, the foundational step is expanding blood volume. Because splanchnic blood pooling during digestion exacerbates central hypovolemia, aggressively increasing total blood volume helps buffer the system against these post-meal drops in stroke volume. This is primarily achieved through high-dose sodium and electrolyte supplementation, which forces the body to retain fluid and fill the vascular space.
Clinical guidelines for POTS generally recommend a significantly elevated sodium intake, often ranging from 3 to 10 grams of sodium per day, depending on the patient's specific presentation and provider recommendations. This is not achieved through diet alone; it requires targeted electrolyte supplements, salt tablets, or specialized hydration formulas. By maintaining a robust blood volume, the cardiovascular system is better equipped to handle the blood diversion required for digestion without triggering severe compensatory tachycardia.
It is crucial to choose high-quality electrolyte supplements that provide a balanced ratio of sodium, potassium, and magnesium, as cellular hydration depends on this delicate balance. Furthermore, patients must pair this high sodium intake with copious amounts of water—often 2 to 3 liters daily. This combination of salt and water acts as a pharmacological intervention, mechanically supporting blood pressure and reducing the severity of postprandial autonomic flares.
Beyond basic hydration, supporting cellular health and calming the hyperactive nervous system are critical components of managing dysautonomia. Omega-3 fatty acids, specifically EPA and DHA, play a vital role in maintaining cellular membrane integrity and reducing systemic inflammation. Research suggests that high-quality Omega-3 supplementation can help calm the nervous system and improve endothelial function, potentially aiding in better blood vessel constriction and reducing the severity of brain fog associated with blood sugar swings.
Additionally, the constant cycle of adrenaline dumps and sympathetic overdrive places an enormous burden on the body's stress response systems. Adaptogenic herbs, which help the body modulate its response to physiological stress, can be highly beneficial. Supplements containing adaptogens and cellular energy supports like Peak ATP may help stabilize energy levels, mitigate the exhaustion that follows a reactive hypoglycemic crash, and support overall mitochondrial function, which is often impaired in chronic complex illnesses.
For patients whose fatigue and orthostatic intolerance are compounded by poor oxygen transport, evaluating iron status is also essential. Iron is critical for red blood cell production and oxygen delivery to the brain. If a patient is deficient, supplementing with a highly absorbable form like Iron Bisglycinate can support energy metabolism and improve the body's resilience against the hypoxic stress caused by splanchnic blood pooling during digestion.
To directly address the insulin resistance and rapid glucose fluctuations seen in dysautonomia, certain targeted nutrients can be employed. Chromium picolinate, for example, is a trace mineral that has been shown in clinical literature to enhance insulin sensitivity at the cellular level. By making the cells more receptive to insulin, the pancreas does not need to overproduce insulin in response to a meal, thereby flattening the insulin curve and preventing the subsequent reactive hypoglycemic crash.
Other cellular energy supports, such as Alpha-Lipoic Acid (ALA) or comprehensive multivitamin blends designed for chronic illness recovery, can support metabolic pathways. Formulations like Women's Nutrients often contain a spectrum of B-vitamins and antioxidants that are crucial for glucose metabolism and neurological health. Supporting these foundational metabolic pathways helps the body process macronutrients more efficiently, reducing the physiological stress of digestion.
Crucially, patients must always consult with a knowledgeable healthcare provider before starting or stopping any supplement regimen. This is a hard requirement, especially for individuals with complex conditions like POTS and dysautonomia, where the autonomic nervous system is highly sensitive. Supplements can interact with prescribed medications (such as beta-blockers or fludrocortisone) and must be tailored to the individual's specific lab results and clinical presentation.
Because the massive release of GIP and insulin is triggered primarily by simple carbohydrates, adopting a low-glycemic index (GI) diet is universally recognized as a first-line management strategy for POTS. The glycemic index measures how quickly a food raises blood sugar levels. High-GI foods (like white bread, sugary drinks, potatoes, and white rice) cause rapid spikes in glucose, triggering the catastrophic hormonal cascade that leads to splanchnic pooling and tachycardia.
Transitioning to a low-GI diet involves swapping these fast-acting carbohydrates for complex, slow-digesting alternatives. This means prioritizing non-starchy vegetables, legumes, whole intact grains (like quinoa or steel-cut oats), and foods rich in dietary fiber. Because these foods take much longer to break down in the digestive tract, glucose is released into the bloodstream slowly and steadily.
This slow release is the key to preventing postprandial POTS flares. By flattening the glucose curve, the body does not need to release massive amounts of GIP or insulin. Without the GIP surge, splanchnic vasodilation is minimized, preventing the severe drop in stroke volume. For many dysautonomia patients, strictly adhering to a low-glycemic diet is as effective as pharmacological interventions in reducing daily symptom burden and preventing reactive hypoglycemic crashes.
Beyond choosing low-GI foods, the way you combine your macronutrients—carbohydrates, proteins, and fats—is critical. A fundamental rule for dysautonomia patients is to never eat "naked carbs." Consuming carbohydrates alone, even complex ones, allows them to be digested and absorbed relatively quickly. To further slow gastric emptying and blunt the insulin response, carbohydrates must always be paired with high-quality proteins and healthy fats.
Protein and fat are incredibly satiating and take significantly longer for the stomach to process. When you eat an apple (a carbohydrate) alongside a handful of almonds (fat and protein), the fat and protein act as a physical barrier in the digestive tract, slowing the absorption of the apple's sugars into the bloodstream. This strategic pairing ensures a slow, sustained release of energy rather than a sharp spike and subsequent crash.
Practical examples of this include adding avocado and olive oil to a salad, pairing a small portion of brown rice with a large serving of salmon and broccoli, or eating Greek yogurt with seeds and berries. By heavily prioritizing proteins and fats in every meal and snack, patients can provide their bodies with stable, long-lasting energy that does not provoke the autonomic nervous system into a state of panic.
The traditional Western dietary pattern of eating three large meals a day is highly disruptive and often dangerous for individuals with POTS. Large volumes of food require massive amounts of blood to be diverted to the GI tract for digestion. For a patient with central hypovolemia and impaired vasoconstriction, eating a heavy meal guarantees severe splanchnic pooling, profound tachycardia, and debilitating post-meal fatigue.
To mitigate this, dysautonomia specialists strongly recommend breaking caloric intake into small, frequent meals throughout the day. Eating five to six small meals or substantial snacks every three to four hours drastically reduces the digestive burden on the circulatory system. Smaller amounts of food require less blood diversion, minimizing the hypotensive drop and preventing the heart from having to race to compensate.
Implementing this strategy requires a shift in mindset and planning. It means carrying low-glycemic, protein-rich snacks at all times and learning to stop eating before feeling completely full. While it can be challenging to adjust to this grazing style of eating, the reduction in postprandial brain fog, tachycardia, and exhaustion makes it one of the most empowering and effective lifestyle modifications a POTS patient can make.
One of the most powerful tools for managing the intersection of blood sugar and dysautonomia is a Continuous Glucose Monitor (CGM). Traditionally used for diabetes management, CGMs are increasingly recommended by autonomic specialists for POTS patients. A CGM is a small wearable device that tracks interstitial glucose levels 24/7, providing real-time data on how specific foods, stress, and activities impact your blood sugar.
For a POTS patient, a CGM is invaluable for identifying hidden reactive hypoglycemic crashes. Because the autonomic nervous system can trigger a severe "adrenaline dump" based on the rate of glucose decline—even if the absolute number hasn't crossed the clinical threshold for hypoglycemia—standard finger-stick tests often miss the problem. A CGM reveals these rapid downward trends, allowing patients to see exactly which meals trigger a crash two hours later.
By tracking this data over a few weeks, patients can create a highly personalized, safe foods list. They can visually see the difference in their glucose curve when they eat "naked carbs" versus properly paired macronutrients. Working with a healthcare provider or a dysautonomia-literate dietitian to interpret this CGM data can rapidly accelerate the process of stabilizing blood sugar and reducing the frequency of postprandial autonomic flares.
A highly effective, non-pharmacological strategy for combating postprandial hypotension and splanchnic blood pooling is the water pre-load. Research has shown that rapidly drinking a large volume of water can induce a significant "pressor effect"—a natural, physiological increase in blood pressure mediated by the sympathetic nervous system. This effect is particularly pronounced in patients with autonomic failure and POTS.
The strategy involves drinking 16 ounces (about 500 mL) of cold water rapidly, approximately 15 to 30 minutes before eating a meal. The sudden influx of water stretches the stomach and triggers osmoreceptors, which signal the nervous system to constrict peripheral blood vessels and raise blood pressure. This temporary boost in vascular tone helps counteract the splanchnic vasodilation that will occur once the food is ingested.
By pre-loading with water, patients essentially give their circulatory system a head start, ensuring that blood pressure is elevated enough to handle the digestive demand without dropping into a hypotensive crisis. This simple, free intervention can significantly reduce the severity of post-meal tachycardia, dizziness, and brain fog, making it a cornerstone of practical POTS management.
Managing diet in dysautonomia is rarely as simple as just watching carbohydrates. A significant percentage of POTS patients also suffer from co-occurring gastrointestinal conditions, most notably Irritable Bowel Syndrome (IBS) and Mast Cell Activation Syndrome (MCAS). These comorbidities add layers of complexity to dietary planning, as foods that are excellent for blood sugar stabilization might trigger severe mast cell reactions or GI distress.
For example, many low-glycemic staples like fermented foods, aged cheeses, and certain legumes are high in histamine. For a patient with MCAS, consuming these foods can trigger massive histamine release, which causes systemic vasodilation, profound tachycardia, and severe allergic-type symptoms that perfectly mimic a POTS flare. In these cases, a patient must navigate a highly restrictive diet that is simultaneously low-glycemic and low-histamine.
Similarly, patients with concurrent IBS may need to integrate a low-FODMAP approach to prevent severe bloating and gas, which can physically press on the vagus nerve and trigger autonomic symptoms. Navigating these overlapping dietary restrictions requires immense patience and, ideally, the guidance of a specialized dietitian. The goal is to find a personalized dietary pattern that stabilizes blood glucose without triggering mast cell degranulation or severe GI dysmotility.
The journey of living with POTS and dysautonomia is often fraught with confusion, especially when the simple act of eating triggers debilitating symptoms. However, understanding the profound physiological connection between blood sugar, gastrointestinal hormones like GIP, and autonomic function is incredibly empowering. It validates the reality of your experience: the post-meal crashes, the racing heart, and the profound fatigue are not in your head; they are measurable, biological reactions to metabolic and circulatory stress.
By recognizing that carbohydrates and large meals actively drive splanchnic blood pooling and reactive hypoglycemia, you gain the tools to intervene. Implementing a low-glycemic diet, prioritizing protein and healthy fats, eating small frequent meals, and utilizing strategies like water pre-loading can drastically alter your daily symptom burden. These dietary modifications are not just lifestyle suggestions; they are powerful, evidence-based treatments that directly counteract the mechanisms driving your dysautonomia flares.
While the dietary changes required can be restrictive and challenging to implement, the return on investment in terms of quality of life is often profound. Many patients find that stabilizing their blood sugar is the key that unlocks a significant reduction in their daily tachycardia, brain fog, and exhaustion, allowing them to engage more fully in their lives and rehabilitation efforts.
Because dysautonomia presents uniquely in every individual, there is no single "perfect" diet. Your management plan must be tailored to your specific metabolic responses, co-occurring conditions like MCAS, and overall health goals. It is absolutely essential to consult with a healthcare provider or a dysautonomia-literate registered dietitian before making drastic changes to your diet or starting new supplements. They can help you safely implement these strategies, interpret CGM data, and ensure you are meeting your nutritional needs.
If you are looking for targeted support to help manage the complex symptoms of Long COVID, ME/CFS, and dysautonomia, Explore RTHM's evidence-based supplements. From high-quality electrolytes for blood volume expansion to cellular supports for metabolic health, finding the right tools can make a significant difference in your recovery journey.
Living with a complex chronic illness requires immense resilience and a willingness to become an expert in your own body. By mastering your blood sugar and understanding how your autonomic nervous system responds to food, you take a massive step forward in reclaiming your stability, your energy, and your life.
Breier, J. et al. (2022). Worsening Postural Tachycardia Syndrome Is Associated With Increased Glucose-Dependent Insulinotropic Polypeptide Secretion. Hypertension. PubMed / PMC9010371
Shibao, C. (2023). Autonomic Regulation of Glucose in POTS. Dysautonomia International. YouTube
Tani, H. et al. (2021). Do meals affect heart rate and symptoms in postural orthostatic tachycardia syndrome? Clinical Autonomic Research. PubMed
Raj, S. R. et al. (2012). Altered systemic hemodynamic & baroreflex response to angiotensin II in postural tachycardia syndrome. Circulation: Arrhythmia and Electrophysiology. AHA Journals
Grubb, B. P. (2007). The postural tachycardia syndrome. Cardiology in Review. LWW
Endocrine Society. (2025). Orthostatic Hypotension, POTS, and Reactive Hypoglycemia: Are they connected? Clinical Case Presentations.
NEISI Institute. (2024). Hypoglycemia in Hypermobile Ehlers-Danlos Syndrome and POTS. Clinical Data Series.
Heart Rhythm Society. (2015). Expert Consensus Statement on the Diagnosis and Treatment of Postural Tachycardia Syndrome, Inappropriate Sinus Tachycardia, and Vasovagal Syncope. Heart Rhythm.